Stroke Care in Central Eastern Europe: Current Problems and Call for Action

Abstract

Stroke is a major medical problem and one of the leading causes of mortality and disability all over in Europe. However, there are significant East-West differences in stroke care as well as in stroke mortality and morbidity rates. Central and Eastern European countries that formerly had centralized and socialist health care systems have serious and similar problems in organizing health and stroke care 20 years after the political transition. In Central and Eastern Europe, stroke is more frequent, the mortality rate is higher, and the victims are younger than in Western Europe. High-risk patients live in worse environmental conditions, and the socioeconomic consequences of stroke further weaken the economic development of these countries. To address these issues, a round table conference was organized. The main aim of this conference was to discuss problems to be solved related to acute and chronic stroke care in Central and Eastern European countries, and also, to exchange ideas on possible solutions. In this article, the discussed problems and possible solutions will be summarized, and introduce 'The Budapest Statement of Stroke Experts of Central and Eastern European countries'.

The Study "Register of Patients After Acute Stroke (Region)". Part 2. Outpatient Prospective Register of Patients After Acute Stroke (According to the Results of the Pilot Phase of the Study)

“…Register of patients who visited an outpatient clinic for the first time after previous ACVA (ACVA-FV register). About 500 (but no less than 450) patients who visited three Ryazan outpatient clinics for ская сердечная недостаточность (ХСН), фибрилляция пред-сердий (ФП) [4,5,[7][8][9][10][11][12].…”

“…Однако реальная клиническая практика лишь в малой сте-пени соответствует тому, что сформулировано в клинических рекомендациях [8][9][10][11][12][13][14]. На повышение качества лечебно-профилактической помощи населению Российской Феде-рации в амбулаторно-поликлинических условиях направ-лено совершенствование системы диспансерного наблю-дения больных ССЗ, в частности, перенесших ОНМК [15].…”

“…Efficacy of acute cerebrovascular accidents (stroke/TIA) secondary prevention in patients with cardiovascular diseases (CVD) is to a great extent determined by effectiveness of measures aimed at blood pressure and serum lipid profile target levels achievement, proper treatment of such prevalent and prognostically important cardiovascular pathology as arterial hypertension, IHD, chronic heart failure (CHF) and atrial fibrillation (AF) [4,5,[7][8][9][10][11][12].…”

“…However real clinical practice only to a small degree corresponds to clinical guidelines [8][9][10][11][12][13][14]. Improvement Мозговой инсульт (МИ) является второй по частоте причиной сердечно-сосудстой смертности после инфарк-та миокарда (ИМ) и основной причиной инвалидизации на-селения в мире.…”

Drug Treatment of Patients With the History of Acute Stroke: Data of the Pilot Phase of the Outpatient Registry «region»

“…Вто-ричная профилактика ОНМК, прежде всего, медика-ментозная терапия с доказанным благоприятным дей-ствием на прогноз, способна существенно снизить как частоту повторного МИ, так и связанную с ним сердечно-сосудистую смертность [4][5][6]. Основные положения первичной и вторичной профилактики МИ сформу-лированы в ряде современных клинических рекомен-даций [3][4][5][6][7][8][9].…”